Rising importance of patient-reported outcomes

Lancet Oncology

Volumn 7, Issue 11, 2006, Pages 883-884

  Atherton, Pamela J ^a   Sloan, Jeff A ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALIBRATION; CANCER SURVIVAL; CLINICAL RESEARCH; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; HEALTH CARE SYSTEM; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MANAGED CARE; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOMETRY; SELF REPORT; SYMPTOM; WELLBEING;

CLINICAL TRIALS; HUMANS; NEOPLASMS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33750287994     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70914-7     Document Type: Letter

References (10)

1. Basch E., Iasonos A., McDonough T., et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7 (2006) 903-909
2. Cleeland C., and Reyes-Gibby C. When is it justified to treat symptoms? Measuring Symptom Burden. Oncology (Williston Park) 16 suppl 10 (2002) 64-70
3. Degner L., and Sloan J. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 10 (1995) 1-8
4. Sloan J., Loprinzi C., Laurine J., et al. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol 19 (2001) 3539-3546
5. Frost M., and Huschka M. Quality of life from a patient's perspective: can we believe the patient?. Current Probl Cancer 29 (2005) 326-331
6. Sneeuw K., Aaronson N., Sprangers M., et al. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51 (1998) 617-631
7. Sneeuw K., Sprangers M., and Aaronson N. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 55 (2002) 1130-1143
8. Morton R., Sloan J., Grothey A., et al. A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. Proc Am Soc Clin Oncol 23 suppl 16 (2005) 750s (abstr 8087)
9. Burger K., and Huschka M. Does QOL provide the same information as toxicity data?. Curr Probl Cancer (2006) (in press)
10. Trotti A., and Bentzen S. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22 (2004) 9-22